Pentoxifylline effect in reduction of serum C-Reactive Protein (CRP) level in hemodialysis patients
Phase 2
- Conditions
- ?End Stage Renal Disease.?End Stage Renal Disease
- Registration Number
- IRCT138901293744N1
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
hemodialysis patients with ESRD (?End Stage Renal Disease) in Booali Sina's hemodialysis center. Exclusion criteria: history of Hypersensitivity to Pentoxifylline, Xanthines (eg, caffeine, theophylline), or any component of the formulation; recent cerebral and/or retinal hemorrhage; inflamatory situations (such as connective tissue Dis., diabetic foot and other vascular problems, active infections, malignancies, recent traumas, wounds and surgeries); and take any anti-inflamatory drugs in 2 months prior to trial.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum CRP. Timepoint: Before intervention and four months later. Method of measurement: mg/liter with lab-kit(nephlometry).
- Secondary Outcome Measures
Name Time Method